EMA Grants Accelerated Assessment for CSL Behring's Haemophilia B Gene Therapy
/PRNewswire/ -- CSL Behring today announced that the European Medicines Agency (EMA) has granted its approval for an accelerated assessment request for...
Source: prnewswire.com